IntelliCell BioSciences

IntelliCell BioSciences is a United States-based company located in New York, New York. With 3 employees, the company generates $2.5 million in annual revenue. IntelliCell BioSciences specializes in a proprietary medical process that isolates Vascular Fraction Cells (VFC) from a patient's own body. VFCs are a rich source of various cell types, including adult stem cells, endothelial cells, and fibroblast cells. These cells are used in research projects and clinical trials worldwide, offering potential treatments for a range of serious diseases. IntelliCell's unique approach involves a patent-pending, chemical-free ultrasound process for VFC isolation. This method, similar to the acquisition of autologous stem cells from bone marrow aspirate, provides physicians in the regenerative medicine field with a valuable tool for treating patients. For more information about IntelliCell BioSciences and their innovative VFC technology, please visit their website at intellicellbiosciences.com.